Kang ZF et al. (2013). Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia. 56 [PubMed]
See more from authors:
Kang ZF
·
Deng Y
·
Zhou Y
·
Fan RR
·
Chan JC
·
Laybutt DR
·
Luzuriaga J
·
Xu G
This website requires cookies and limited processing of your personal data in order to function. By continuing to browse
or otherwise use this site, you are agreeing to this use. See our Privacy policy and
how to cite and terms of use.